ENTITY

Dermira Inc (1934798D US)

Health Care • United States

Dermira, Inc. develops and commercializes dermatology therapies. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Dermira serves patients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00